42 CFR §424.68
Verified against eCFR.gov as of June 20, 2026View official text on eCFR.gov ↗
- (a)Definition. For purposes of this section, a home infusion therapy supplier means a supplier of home infusion therapy that meets all of the following requirements:
- (1)Furnishes infusion therapy to individuals with acute or chronic conditions requiring administration of home infusion drugs.
- (2)Ensures the safe and effective provision and administration of home infusion therapy on a 7-day-a-week, 24-hour-a-day basis.
- (3)Is accredited by an organization designated by the Secretary in accordance with section 1834(u)(5) of the Act.
- (4)Is enrolled in Medicare as a home infusion therapy supplier consistent with the provisions of this section and subpart P of this part.
- (b)General requirement. For a supplier to receive Medicare payment for the provision of home infusion therapy supplier services, the supplier must qualify as a home infusion therapy supplier (as defined in this section) and be in compliance with all applicable provisions of this section and of subpart P of this part.
- (c)Specific requirements for enrollment. To enroll in the Medicare program as a home infusion therapy supplier, a home infusion therapy supplier must meet all of the following requirements:
- (1)
- (i)Fully complete and submit the Form CMS-855B application (or its electronic or successor application) to its applicable Medicare contractor.
- (ii)Certify via the Form CMS-855B that the home infusion therapy supplier meets and will continue to meet the specific requirements and standards for enrollment described in this section and in subpart P of this part.
- (2)Comply with the application fee requirements in § 424.514.
- (3)Be currently and validly accredited as a home infusion therapy supplier by a CMS-recognized home infusion therapy supplier accreditation organization.
- (4)Comply with § 414.1515 of this chapter and all provisions of part 486, subpart I of this chapter.
- (5)Successfully complete the limited categorical risk level of screening under § 424.518.
- (1)
- (d)Denial of enrollment.
- (1)Enrollment denial by CMS. CMS may deny a supplier's enrollment application as a home infusion therapy supplier on either of the following grounds:
- (2)Appeal of an enrollment denial. A supplier may appeal the denial of its enrollment application as a home infusion therapy supplier under part 498 of this chapter.
- (e)Continued compliance, standards, and reasons for revocation.
- (1)Upon and after enrollment, a home infusion therapy supplier—
- (2)CMS may revoke a home infusion therapy supplier's enrollment on any of the following grounds:
- (3)A home infusion therapy supplier may appeal the revocation of its enrollment under part 498 of this chapter.